January 2025, the U.S. Securities and Exchange Commission (SEC) approved amendments, both of which are now effective, to The Nasdaq Stock Market ...

Additional information about the reverse stock split can be found in the Current Report on Form 8-K filed today and in the Company’s definitive proxy statement (Form DEF 14A) filed with the United ...

Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced that it will proceed with a 1-for-150 reverse stock split ...

Windtree Therapeutics (WINT) board of directors has approved a 1-for-50 reverse stock split of the Company’s common stock. The Company’s ...

The Securities and Exchange Commission (SEC) recently approved rule changes proposed by The Nasdaq Stock Market LLC that impact companies ...

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

MENLO PARK, Calif. - Cyngn Inc. (NASDAQ:CYN), a developer of autonomous vehicle technology with a current market capitalization of $3.23 million, has announced a 1-for-150 reverse stock split of its ...

Under the reverse stock split that took effect after the markets closed Monday, 15 shares of Globalstar stock will be ...

Class A Common Stock Expected to Begin Trading on Reverse-Split Adjusted Basis on February 18, 2025 Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology solutions ...

MENLO PARK, Calif., Feb. 13, 2025 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced that it will proceed with a 1-for-150 reverse stock split ("Reverse Stock ...

The reverse stock split is intended to regain compliance with the minimum bid price requirement of $1.00 per share of the Company’s common stock for continued listing on The Nasdaq Capital Market.